Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
36231 | 84 | 29.4 | 52% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | ENVIRONMENTAL SCIENCES//GEOSCIENCES, MULTIDISCIPLINARY//METEOROLOGY & ATMOSPHERIC SCIENCES | 1766162 |
184 | 3 | METALLOTHIONEIN//WILSONS DISEASE//CADMIUM | 56156 |
443 | 2 | LEAD//CADMIUM//BLOOD LEAD | 16200 |
36231 | 1 | CELLFOOD R//CHELAT THERAPY//DESCRIPTIVE DECISION MODELING | 84 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CELLFOOD R | authKW | 363520 | 1% | 100% | 1 |
2 | CHELAT THERAPY | authKW | 363520 | 1% | 100% | 1 |
3 | DESCRIPTIVE DECISION MODELING | authKW | 363520 | 1% | 100% | 1 |
4 | ELASTIN ANTIBODY | authKW | 363520 | 1% | 100% | 1 |
5 | ETHYLENEDIAMINE TETRAACETICACID | authKW | 363520 | 1% | 100% | 1 |
6 | SELF EVALUATION BINNENANERKENNUNG | authKW | 363520 | 1% | 100% | 1 |
7 | TARGETED EDTA CHELATION THERAPY | authKW | 363520 | 1% | 100% | 1 |
8 | TRIAL TO ASSESS CHELATION THERAPY | authKW | 363520 | 1% | 100% | 1 |
9 | EDTA CHELATION | authKW | 242344 | 2% | 33% | 2 |
10 | CELLFOOD TM | authKW | 181759 | 1% | 50% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medicine, General & Internal | 186 | 23% | 0% | 19 |
2 | Cardiac & Cardiovascular System | 180 | 19% | 0% | 16 |
3 | Medicine, Research & Experimental | 90 | 13% | 0% | 11 |
4 | Integrative & Complementary Medicine | 67 | 4% | 0% | 3 |
5 | Medical Ethics | 30 | 1% | 0% | 1 |
6 | Peripheral Vascular Diseases | 27 | 6% | 0% | 5 |
7 | Veterinary Sciences | 25 | 7% | 0% | 6 |
8 | Pharmacology & Pharmacy | 22 | 12% | 0% | 10 |
9 | Toxicology | 15 | 5% | 0% | 4 |
10 | Geriatrics & Gerontology | 13 | 2% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HAEMATOL ONCOL BMT UNIT | 121172 | 1% | 33% | 1 |
2 | NRFL | 90876 | 2% | 13% | 2 |
3 | CLIN CARDIOVASC BIOL | 36350 | 1% | 10% | 1 |
4 | SMALL ANIM IL | 33045 | 1% | 9% | 1 |
5 | GEORGIA POISON | 24233 | 1% | 7% | 1 |
6 | CRAIGAVON CARDIAC | 22718 | 1% | 6% | 1 |
7 | NVMC | 22718 | 1% | 6% | 1 |
8 | DIPARTIMENTO MORFOL UMANA SCI BIOMED | 21382 | 1% | 6% | 1 |
9 | BHNRC | 14684 | 2% | 2% | 2 |
10 | MT SINAI MED | 12076 | 10% | 0% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE | 17200 | 5% | 1% | 4 |
2 | ALTERNATIVE MEDICINE REVIEW | 11356 | 2% | 2% | 2 |
3 | TEXAS MEDICINE | 5632 | 2% | 1% | 2 |
4 | JOURNAL OF ORTHOMOLECULAR MEDICINE | 5591 | 1% | 2% | 1 |
5 | JOURNAL OF ORTHOMOLECULAR PSYCHIATRY | 3105 | 1% | 1% | 1 |
6 | MEDICAL HYPOTHESES | 2502 | 10% | 0% | 8 |
7 | DANISH MEDICAL BULLETIN | 1021 | 2% | 0% | 2 |
8 | NATURE REVIEWS CARDIOLOGY | 853 | 1% | 0% | 1 |
9 | FORSCHENDE KOMPLEMENTARMEDIZIN | 781 | 1% | 0% | 1 |
10 | MINNESOTA MEDICINE | 780 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CELLFOOD R | 363520 | 1% | 100% | 1 | Search CELLFOOD+R | Search CELLFOOD+R |
2 | CHELAT THERAPY | 363520 | 1% | 100% | 1 | Search CHELAT+THERAPY | Search CHELAT+THERAPY |
3 | DESCRIPTIVE DECISION MODELING | 363520 | 1% | 100% | 1 | Search DESCRIPTIVE+DECISION+MODELING | Search DESCRIPTIVE+DECISION+MODELING |
4 | ELASTIN ANTIBODY | 363520 | 1% | 100% | 1 | Search ELASTIN+ANTIBODY | Search ELASTIN+ANTIBODY |
5 | ETHYLENEDIAMINE TETRAACETICACID | 363520 | 1% | 100% | 1 | Search ETHYLENEDIAMINE+TETRAACETICACID | Search ETHYLENEDIAMINE+TETRAACETICACID |
6 | SELF EVALUATION BINNENANERKENNUNG | 363520 | 1% | 100% | 1 | Search SELF+EVALUATION+BINNENANERKENNUNG | Search SELF+EVALUATION+BINNENANERKENNUNG |
7 | TARGETED EDTA CHELATION THERAPY | 363520 | 1% | 100% | 1 | Search TARGETED+EDTA+CHELATION+THERAPY | Search TARGETED+EDTA+CHELATION+THERAPY |
8 | TRIAL TO ASSESS CHELATION THERAPY | 363520 | 1% | 100% | 1 | Search TRIAL+TO+ASSESS+CHELATION+THERAPY | Search TRIAL+TO+ASSESS+CHELATION+THERAPY |
9 | EDTA CHELATION | 242344 | 2% | 33% | 2 | Search EDTA+CHELATION | Search EDTA+CHELATION |
10 | CELLFOOD TM | 181759 | 1% | 50% | 1 | Search CELLFOOD+TM | Search CELLFOOD+TM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHRIHARI, JS , ROY, A , PRABHAKARAN, D , REDDY, KS , (2006) ROLE OF EDTA CHELATION THERAPY IN CARDIOVASCULAR DISEASES.NATIONAL MEDICAL JOURNAL OF INDIA. VOL. 19. ISSUE 1. P. 24-26 | 14 | 100% | 4 |
2 | IBAD, A , KHALID, R , THOMPSON, PD , (2016) CHELATION THERAPY IN THE TREATMENT OF CARDIOVASCULAR DISEASES.JOURNAL OF CLINICAL LIPIDOLOGY. VOL. 10. ISSUE 1. P. 58 -62 | 10 | 91% | 0 |
3 | MEYER, FP , (1998) ABOUT THE 'OMNIPOTENCE' OF THE CHELATION THERAPY.FORSCHENDE KOMPLEMENTARMEDIZIN. VOL. 5. ISSUE 6. P. 266-271 | 12 | 86% | 0 |
4 | SIDHU, MS , SAOUR, BM , BODEN, WE , (2014) A TACTFUL REAPPRAISAL OF CHELATION THERAPY IN CARDIOVASCULAR DISEASE.NATURE REVIEWS CARDIOLOGY. VOL. 11. ISSUE 3. P. 180-183 | 8 | 67% | 2 |
5 | ERNST, E , (1997) CHELATION THERAPY FOR PERIPHERAL ARTERIAL OCCLUSIVE DISEASE - A SYSTEMATIC REVIEW.CIRCULATION. VOL. 96. ISSUE 3. P. 1031-1033 | 7 | 100% | 40 |
6 | QUAN, H , GALBRAITH, PD , NORRIS, CM , SOUTHERN, DA , KING, K , VERHOEF, MJ , KNUDTSON, ML , GHALI, WA , (2007) OPINIONS ON CHELATION THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: CROSS-SECTIONAL SURVEY.CANADIAN JOURNAL OF CARDIOLOGY. VOL. 23. ISSUE 8. P. 635-640 | 8 | 67% | 1 |
7 | LAMAS, GA , GOERTZ, C , BOINEAU, R , MARK, DB , ROZEMA, T , NAHIN, RL , DRISKO, JA , LEE, KL , (2012) DESIGN OF THE TRIAL TO ASSESS CHELATION THERAPY (TACT).AMERICAN HEART JOURNAL. VOL. 163. ISSUE 1. P. 7-12 | 7 | 47% | 15 |
8 | LAMAS, GA , GOERTZ, C , BOINEAU, R , MARK, DB , ROZEMA, T , NAHIN, RL , LINDBLAD, L , LEWIS, EF , DRISKO, J , LEE, KL , (2013) EFFECT OF DISODIUM EDTA CHELATION REGIMEN ON CARDIOVASCULAR EVENTS IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION THE TACT RANDOMIZED TRIAL.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 309. ISSUE 12. P. 1241 -1250 | 7 | 37% | 44 |
9 | AVILA, MD , ESCOLAR, E , LAMAS, GA , (2014) CHELATION THERAPY AFTER THE TRIAL TO ASSESS CHELATION THERAPY: RESULTS OF A UNIQUE TRIAL.CURRENT OPINION IN CARDIOLOGY. VOL. 29. ISSUE 5. P. 481 -488 | 8 | 38% | 4 |
10 | LAMAS, GA , ISSA, OM , (2016) EDETATE DISODIUM-BASED TREATMENT FOR SECONDARY PREVENTION IN POST-MYOCARDIAL INFARCTION PATIENTS.CURRENT CARDIOLOGY REPORTS. VOL. 18. ISSUE 2. P. - | 10 | 29% | 0 |
Classes with closest relation at Level 1 |